Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 42708-172

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 42708-172). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (42708 172 20 Rev 1)

Label (42708 172 20   Rev 1)
This document appears to be a prescription label for Cyclobenzaprine Hydrochloride Tablets USP, 5mg. The recommended dosage is to take the tablets twice a day or as prescribed by a doctor. The label suggests taking 20 tablets every few hours for a specified number of days, but the blank spaces where this information should be filled out make it unclear. It also notes that the medication requires a prescription from a healthcare professional.*
FDA Label Image

Chemical Structure (Cyclobenz Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.